Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.
Jimenez V, Sacristan V, Jambrina C, Jaen ML, Casana E, Muñoz S, Marcó S, Molas M, Garcia M, Grass I, León X, Elias I, Ribera A, Elias G, Sanchez V, Vilà L, Casellas A, Ferre T, Rodó J, Carretero A, Pumarola M, Navarro M, Andaluz A, Moll X, Añor S, Franckhauser S, Vergara M, Caixàs A, Bosch F.
Jimenez V, et al. Among authors: vergara m.
Mol Ther. 2024 Oct 28:S1525-0016(24)00683-X. doi: 10.1016/j.ymthe.2024.10.023. Online ahead of print.
Mol Ther. 2024.
PMID: 39489916
Free article.